Meng-Han is a PhD graduate who has joined Thermo Fisher Scientific in Brisbane as an Upstream Bioprocess Scientist for making therapeutic biologics for clinical trials. Meng-Han undertook his PhD under the supervision of Dr Edward Gilding, Dr Mark Jackson and Prof David Craik at the Institute for Molecular Bioscience, The University of Queensland. His interests include understanding the biosynthesis of disulfide-rich proteins and developing ways to improve the scale-up production of therapeutics in recombinant expression systems.